A potential patient stratification biomarker for Parkinson's disease based on LRRK2 kinase-mediated centrosomal alterations in peripheral blood-derived cells
Yahaira Naaldijk, Belén Fernández, Rachel Fasiczka, Elena Fdez, Coline Leghay, Ioana M. Croitoru, John B. Kwok, Yanisse Boulesnane, Amélie Vizeneux, Eugénie Mutez, Camille Calvez, A. Destée, Jean‐Marc Taymans, Ana Vinagre‐Aragón, Alberto Bergareche‐Yarza, , Sabine Hilfiker
Peripheral blood-derived cells can be employed to stratify Parkinson's disease patients most likely to respond to LRRK2-related therapeutics.
bioRxiv · Apr 11, 2023 · PreprintNeuroscience